Enoticumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | DLL4 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG |
|
Enoticumab (INN) is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.[1]
References
- ↑ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | |||||||||
---|---|---|---|---|---|---|---|---|---|
Bone ("-os-", "-s(o)-") |
| ||||||||
Musculoskeletal ("-mul-") |
| ||||||||
Circulatory ("-c(i[r])-") |
| ||||||||
Neurologic ("-ne(u)(r)-") |
| ||||||||
Angiogenesis inhibitor ("-anibi-") |
| ||||||||
Growth factor ("-gr(o)-") |
| ||||||||
|
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.